Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

60.22 -0.81 (-1.33%)
Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
40 41 Next >
Help Grow Your Retirement Savings by Investing in These 3 Safe Stocks for the Long Haul
These are stocks you can comfortably hold in your portfolio for decades. 
Via The Motley Fool
Topics Retirement
Exposures Pension
CVS Health Is Down 27% This Year. Is the Stock a Buy on the Dip?
At recent prices, the healthcare giant offers a 3.5% dividend yield. 
Via The Motley Fool
What 7 Analyst Ratings Have To Say About CVS Health
Via Benzinga
Wait for the New CEO to Get His Feet Wet Before You Trust Too Much in Walgreens' Guidance
Walgreens just hired a new CEO, which means any guidance that exists today has minimal value for investors. 
Via The Motley Fool
3 Beaten-Down, High-Yield Dividend Stocks That Wall Street Predicts Could Soar More Than 25% Over the Next 12 Months
Analysts view these dividend stocks as great rebound candidates. 
Via The Motley Fool
Why CVS Health Stock Dropped Today
The pharmacy chain modestly lowered its full-year outlook despite strong third-quarter results. 
Via The Motley Fool
CVS Health Unusual Options Activity For October 31
Via Benzinga
Earnings Preview: CVS Health
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
CVS Health Unusual Options Activity For October 17
Via Benzinga
CVS Health (CVS) Q3 2023 Earnings Call Transcript
CVS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CVS Health's Health Services And Pharmacy Benefit Management Business Show Strength In Q3, But Lowers Annual GAAP EPS Outlook
CVS Health Corp's (NYSE: CVS) Q3 sales increased 10.6% Y/Y to $89.76 billion, beating the consen 
Via Benzinga
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision
The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Kraft Heinz, Yum China And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
Workers at pharmacy companies CVS, Walgreens and RiteAid have staged a three-day strike over unsafe and poor working conditions. 
Via InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
Exposures COVID-19
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC: 
Via Benzinga
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun 
Via Benzinga
Exposures Product Safety
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
The U.S. 
Via Benzinga
Exposures Product Safety
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S.... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare business. "It’s not a healthcare business that is a retailer, and retail... 
Via Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend. 
Via The Motley Fool
WBA Stock Jumps On Upgrade, Target Hike. New CEO, 'New Era' Analyst Says
JPMorgan expects Walgreens' new CEO to usher in "a new era" for the Dow Jones giant. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why This Drugstore Will Avoid Rite Aid’s Bankruptcy Fate
The top three drugstores are having a meltdown due to pressures. Today, I’ll walk through what those pressures are, each company’s issues, and point out which one of these drugstores is unfairly... 
Via Talk Markets
Topics Bankruptcy
Exposures Financial Legal
CVS Removes Certain Cold, Cough Products With Phenylephrine From Shelves: Report
CVS Health Corp (NYSE: CVS) has reportedly decided to remove specific decongestant products from its stores after an advisory by a panel to U.S. health regulators found an ingredient in these products,... 
Via Benzinga
In Need of a Turnaround: Will Walgreens' New CEO Cut or Spare Its High-Yield Dividend?
A healthcare and pharmaceutical benefits manager veteran is coming in to lead the turnaround. 
Via The Motley Fool
Mondelez, CVS Health, Shell And A Major Retailer On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors said Mondelez International, Inc. (NASDAQ: MDLZ), has "fantastic" 
Via Benzinga
Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
Walgreens stock became a clear value play, offering an attractive dividend yield and tailwinds to position it as an industry leaders are two reasons to watch 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Economy
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.